Mekonos, Inc. — Form D
Mekonos, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-09. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-11-09
- Form: D
- Accession: 0001838228-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $25.0M
- Remaining: $20K
- Investors: 23
- Date of first sale: 2021-10-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-420432
Issuer
- Name: Mekonos, Inc.
- CIK: 0001838228
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 44 MONTGOMERY STREET, SUITE 300, SAN FRANCISCO, CA, 94104
- Phone: (408) 857-2014
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| KURT KEILHACKER | Director | GREENWICH, CT |
| Anil Narasimha | Director | San Francisco, CA |
| Neil Tiwari | Director | Cambridge, MA |
| Anil Narasimha | Executive Officer | San Francisco, CA |
| Gregory Sitters | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More